Empery Asset Management, LP reported 14 positions worth $72.85M for the quarter ended Jun 30, 2026, down 6.0% on the prior quarter. It opened 5 new positions, added to 0, trimmed 6 and exited 4. Its largest holding is X4 Pharmaceuticals, Inc at 44.4% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | -2.01M | -22.5% | $9.40M | 44.43% |
| DTIL Precision Biosciences Inc | -1.19M | -60.6% | $9.38M | 8.37% |
| IMPP Imperial Petroleum Inc./Marshall Islands | -877.6K | -100.0% | $3.76M | Exited |
| BSIN Big Sky Industrial Inc. | -1.92M | -100.0% | $1.70M | Exited |
| VENU Venu Holding Corp | -494.9K | -49.1% | $1.12M | 1.6% |
| CRML Critical Metals Corp. | -132.0K | -100.0% | $1.05M | Exited |
| SCYX Scynexis Inc | -104.5K | -45.3% | $425.43K | 0.706% |
| BNTC Benitec Biopharma Inc. | -30.4K | -100.0% | $324.19K | Exited |
| TNYA Tenaya Therapeutics, Inc. | -423.8K | -9.9% | $313.24K | 3.92% |
| CYN Cyngn Inc. | -30.7K | -3.2% | $42.71K | 1.77% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XFOR X4 Pharmaceuticals, Inc | Healthcare | 6.93M | $32.37M | 44.43% | -2.01M | -22.5% | Reduced | 5.49% |
| 2 | EMPD Empery Digital Inc. | Financial Services | 2.93M | $10.43M | 14.32% | 0 | 0.0% | Unchanged | 10.42% |
| 3 | DTIL Precision Biosciences Inc | Healthcare | 776.1K | $6.10M | 8.37% | -1.19M | -60.6% | Reduced | 2.94% |
| 4 | CLNN Clene Inc. | Healthcare | 916.5K | $5.64M | 7.74% | +916.5K | – | New | 7.17% |
| 5 | ANVS Annovis Bio, Inc. | Healthcare | 2.40M | $4.47M | 6.13% | +2.40M | – | New | 5.64% |
| 6 | LTRN Lantern Pharma Inc. | Healthcare | 842.7K | $3.51M | 4.82% | +842.7K | – | New | 6.6% |
| 7 | AMC Amc Entertainment Holdings, Inc. | Communication Services | 1.71M | $3.26M | 4.47% | +1.71M | – | New | 0.24% |
| 8 | TNYA Tenaya Therapeutics, Inc. | Healthcare | 3.86M | $2.86M | 3.92% | -423.8K | -9.9% | Reduced | 1.72% |
| 9 | CYN Cyngn Inc. | Technology | 927.1K | $1.29M | 1.77% | -30.7K | -3.2% | Reduced | 6.43% |
| 10 | VENU Venu Holding Corp | Consumer Discretionary | 512.8K | $1.16M | 1.6% | -494.9K | -49.1% | Reduced | 0.86% |
| 11 | URG Ur-Energy Inc | Energy | 620.1K | $843.39K | 1.16% | 0 | 0.0% | Unchanged | 0.16% |
| 12 | SCYX Scynexis Inc | Healthcare | 126.5K | $514.66K | 0.706% | -104.5K | -45.3% | Reduced | 1.07% |
| 13 | RNTX Rein Therapeutics, Inc. | Healthcare | 370.8K | $385.67K | 0.529% | +370.8K | – | New | 0.43% |
| 14 | MDAIW Spectral AI, Inc. | Healthcare | 33.3K | $18.50K | 0.025% | 0 | 0.0% | Unchanged | 0% |
Tip. Select a row to see that position’s full history at Empery Asset Management.
As of its Q2 2026 13F filing, Empery Asset Management, LP’s five largest positions were X4 Pharmaceuticals, Inc (XFOR) at 44.4%, Empery Digital Inc. (EMPD) at 14.3%, Precision Biosciences Inc (DTIL) at 8.4%, Clene Inc. (CLNN) at 7.7%, Annovis Bio, Inc. (ANVS) at 6.1% of the reported portfolio.
Empery Asset Management, LP reported a 13F portfolio worth $72.85M across 14 positions for Q2 2026. That is down 6.0% from the previous quarter.
Its largest purchases by value were Clene Inc. ($5.64M), Annovis Bio, Inc. ($4.47M), Lantern Pharma Inc. ($3.51M). It opened 5 new positions.
Its largest sales by value were X4 Pharmaceuticals, Inc ($9.40M), Precision Biosciences Inc ($9.38M), Imperial Petroleum Inc./Marshall Islands ($3.76M). It exited 4 positions entirely.
From the Form 13F-HR reports Empery Asset Management, LP files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.